Lifeline SPAC I Plc, a special purpose acquisition company (SPAC) listed on the London Stock Exchange, has released its financial statements for the 2022 calendar year. The company, which was founded in 2021, is focused on acquiring and investing in companies in the healthcare and life sciences sectors.
The financial statements show that Lifeline SPAC I Plc had a net income of £2.9 million for the year, up from £1.8 million in 2021. This increase was driven by strong performance in the company’s investments in the healthcare and life sciences sectors. The company also reported a total revenue of £6.3 million, up from £3.7 million in 2021.
The company’s balance sheet shows that it has total assets of £18.2 million, up from £13.1 million in 2021. This increase was largely due to the company’s investments in the healthcare and life sciences sectors. The company also reported total liabilities of £4.2 million, up from £2.8 million in 2021.
The company’s cash flow statement shows that it had a net cash flow from operating activities of £3.3 million for the year, up from £2.4 million in 2021. This increase was primarily due to increased revenue from its investments in the healthcare and life sciences sectors.
Overall, Lifeline SPAC I Plc had a successful year in 2022, with strong performance in its investments in the healthcare and life sciences sectors driving its financial results. The company’s balance sheet and cash flow statement also show that it is well-positioned to continue to grow and invest in the future.
Source: Plato Data Intelligence: PlatoAiStream
